Bill117th CongressFiled May 25, 2022Health
S. 4302
Biologics Market Transparency Act of 2022
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in senate (May 25, 2022)
Biologics Market Transparency Act of 2022
This bill requires biologics manufacturers to notify the Food and Drug Administration in advance of withdrawing a product from sale.
What just happenedMay 25, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709)
Who’s behind it
Sen. Kaine, Tim [D-VA](D-VA)Sponsor
3 cosponsors1 D2 R
3cosponsors1committees2actions3related bills
- Introduced in SenateMay 25, 2022
- May 25, 2022IntroReferral
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709)
Health, Education, Labor, and Pensions Committee - May 25, 2022IntroReferral10000
Introduced in Senate